New Market Research Report: Progenra, Inc. - Product Pipeline Analysis, 2013 Update
Progenra, Inc. (Progenra) is a biotechnology company. The company discovers and develops therapeutic medicines. Its products under clinical development include P005091, P013222, and P009492. Progenra's products are used in the areas of oncology, muscle wasting, central nervous system, lipid metabolism, and inflammation. The company develops products of various compounds, which modulate DUB and E3 ligase activities. Its DUB technology platform utilizes substrate specific assays to identify selective small molecule inhibitors of DUBs. The company also develops ligase technology platform that...
View full press release